Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, London, UK; University College London Hospitals Biomedical Research Center, National Institute for Health Research, London, UK.
Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.
Lancet Neurol. 2019 Feb;18(2):185-197. doi: 10.1016/S1474-4422(18)30460-5.
Spinal cord involvement is an important cause of disability in patients with multiple sclerosis or neuromyelitis optica spectrum disorders (NMOSDs). Multiple sclerosis and NMOSDs can be distinguished from other disorders that cause myelopathy by results from laboratory and radiological investigations. However, limitations in the sensitivity and specificity of spinal cord imaging and poor correlation with disability megasures have impeded the understanding of the relationship between spinal cord involvement and clinical manifestations. Nevertheless, studies of the pathological features of multiple sclerosis and NMOSDs have shown that quantitatively different mechanisms lead to differences in clinical course and pattern of accrual of permanent disability in the two disorders. Better understanding of these mechanisms is necessary to develop more informative clinical measures, electrophysiological methods, fluid biomarkers, and imaging techniques to detect and monitor spinal cord involvement in the diagnosis and management of patients with multiple sclerosis or NMOSDs, and as outcome measures in clinical trials.
脊髓病变是多发性硬化症或视神经脊髓炎谱系疾病(NMOSD)患者残疾的重要原因。通过实验室和影像学检查结果,可将多发性硬化症和 NMOSD 与导致脊髓病变的其他疾病区分开来。然而,脊髓成像的敏感性和特异性存在局限性,与残疾测量的相关性较差,这阻碍了对脊髓病变与临床表现之间关系的理解。尽管如此,对多发性硬化症和 NMOSD 的病理特征的研究表明,定量不同的机制导致这两种疾病的临床病程和永久性残疾累积模式存在差异。为了开发更具信息量的临床措施、电生理方法、液体生物标志物和影像学技术,以检测和监测多发性硬化症或 NMOSD 患者的脊髓病变,并将其作为临床试验的结局指标,有必要更好地了解这些机制。